MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

    O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)

    Objective: We investigated neuroanatomical differences between Parkinson’s disease (PD) patients with and without semantic fluency impairment and explored predictive markers for dementia development. Background: Sematic…
  • 2019 International Congress

    Mild Cognitive Impairment in Parkinson’s disease in South Indian population – Development of a test battery and assessment of prevalence and characteristics

    S. Krishnan Nair, R. Ramesh, G. Sarma, D. Puthenveedu, R. Menon, A. Kishore (Thiruvananthapuram, India)

    Objective: We aimed to design a neuropsychological test battery to diagnose Mild Cognitive Impairment (MCI) and to estimate the prevalence of MCI in Malayalam-speaking patients…
  • 2019 International Congress

    Plasma Soluble ST2 (sST2) levels are Higher in Neurodegeneration and Associate with PD Cognition

    ASL. Ng, YJ. Tan, ACW. Yong, BYX. Wong, ZH. Lu, SYE. Ng, SKS. Ting, S. Hameed, L. Zeng, N. Kandiah, WL. Au, LCS. Tan (Singapore, Singapore)

    Objective: As plasma IL-33 levels are too low to accurately quantify, we measured plasma sST2 as a surrogate marker for IL-33 in samples from healthy…
  • 2019 International Congress

    Introduction of an Assessment Toolkit Increases the Rate of DLB Diagnosis

    A. Surendranathan, J. Kane, A. Bentley, S. Barker, J. Taylor, A. Thomas, I. Mckeith, D. Burn, J. O'Brien (Cambridge, United Kingdom)

    Objective: To assess whether diagnostic rates of both Parkinson’s disease dementia (PDD) and dementia with Lewy bodies (DLB) could be increased by the introduction of…
  • 2019 International Congress

    Prospective Memory in Parkinson’s Disease: the role of the motor subtypes

    A. D'Iorio, G. Maggi, C. Vitale, D. Di Meglio, L. Trojano, G. Santangelo (Caserta, Italy)

    Objective: In the present study, we evaluated whether deficits in Prospective memory (PM) abilities were present to the same extent in tremor dominant patients with…
  • 2019 International Congress

    Imaging correlates of impaired self-awareness of cognitive deficits in Parkinson’s disease

    F. Maier, A. Greuel, M. Hoock, M. Tahmasian, F. Jessen, I. Csoti, L. Timmermann, C. Eggers (Cologne, Germany)

    Objective: To discover the neural basis of impaired self-awareness of cognitive deficits (ISA-cog) in Parkinson’s disease (PD) patients with mild cognitive impairment (MCI). Background: Anosognosia…
  • 2019 International Congress

    Mobility Impairments in Huntington’s Disease due to Cognitive Dysfunction

    M. Rakhimova, N. Yusupova (Tashkent, Uzbekistan)

    Objective: This study examined the relationships of mobility, motor and cognitive function measures at baseline, and of mobility and cognitive measures over four years Background:…
  • 2019 International Congress

    Neuropathological findings in a SPG4 gene mutation carrier

    S. Forcén, I. Aldecoa, AM. Crespo, O. Ramos, L. Ispierto, R. álvarez, D. Vilas (Badalona, Spain)

    Objective: To describe the clinical and neuropathological findings of a patient carrier of a mutation in the SPG4 gene. Background: Hereditary spastic paraplegia (HSP) linked…
  • 2019 International Congress

    Investigating Physical and Cognitive Changes over Two Years in Patients with Moderate to Late Stage Parkinson’s Disease in Northumbria

    L. Macdonald, I. Sayers, S. Dempsey, W. Gray, A. Hand, R. Walker (North Shields, United Kingdom)

    Objective: Investigate changes in timed up and go (TUG), grip strength, MoCA and MMSE scores and explore which areas of cognition are most commonly affected.…
  • 2019 International Congress

    Validation of the Clinical Dementia Rating Scale Sum of Boxes in Parkinson’s Disease

    J. Rick, S. Xie, E. Mamikonyan, B. Deck, S. Rudovsky, A. Chen-Plotkin, N. Dahodwala, J. Morley, J. Duda, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)

    Objective: To assess the psychometric properties of the Clinical Dementia Rating Scale Sum of Boxes (CDR-SOB) in Parkinson’s disease (PD) across levels of cognitive abilities.…
  • « Previous Page
  • 1
  • …
  • 78
  • 79
  • 80
  • 81
  • 82
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley